|
Monday 29th July 2024 |
Text too small? |
Infratil Limited's 30 June 2024 independent valuation update is attached.
As noted in the attached, CDC, Longroad, Galileo, Mint, Qscan and RetireAustralia values reflect the midpoint of the 30 June independent valuations. CDC’s key valuation methodologies and assumptions were presented as part the NZX valuation announcement on 4 July 2024.
Key valuation methodologies and assumptions underpinning the remaining independent valuations are summarised in the attached and remain consistent with the 31 March 2024 valuations [1], except for Longroad (refer below), and an update for the inclusion of storage for Galileo.
The decrease in the Longroad independent valuation is largely attributable to an increase in discount rates outweighing minor positive updates to operating forecasts.
Any enquiries should be directed to:
Mark Flesher, Investor Relations, Infratil Limited
info@infratil.com
[1] 1. Valuation methodologies and assumptions for 31 March 2024 included here: https://api.nzx.com/public/announcement/431367/attachment/418814/431367-418814.pdf
No comments yet
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved
FBU - Fletcher Building sale of Fletcher Reinforcing and Wire